Epinephrine Nebulization Delays Need for Life-Saving Intervention After Smoke Inhalation in Ovine Model

Area of Science:

• Resuscitation Medicine
• Pulmonary Medicine
• Trauma Care

Background:

• Smoke inhalation injury poses a significant threat, often leading to acute respiratory distress syndrome.
• Life-saving interventions (LSI) for smoke inhalation are resource-intensive and may be scarce in austere settings.
• Current treatments for smoke inhalation injury require advanced medical support and resources.

Purpose of the Study:

• To test if nebulized epinephrine can delay the need for life-saving interventions (LSI) in a clinically relevant ovine model of smoke inhalation.
• To evaluate the efficacy of nebulized epinephrine as a potential immediate resuscitation tool for smoke inhalation victims.

Main Methods:

• Adult Merino sheep underwent surgical instrumentation followed by controlled smoke inhalation.
• Sheep were randomly assigned to receive nebulized epinephrine or saline (control) every 4 hours post-injury.
• Key respiratory parameters including FiO2, PaO2/FiO2 ratio, PEEP, and pressure support were monitored hourly to assess the need for LSI.

Main Results:

• Nebulized epinephrine significantly delayed the time until increased oxygen concentration (FiO2 >25% and >30%) was required.
• The epinephrine group showed a significantly longer time until PaO2/FiO2 ratio decreased below 300.
• The need for increased Positive End-Expiratory Pressure (PEEP) was significantly delayed in the epinephrine group, with fewer animals requiring mechanical ventilation.

Conclusions:

• Nebulized epinephrine effectively delays the requirement for life-saving interventions in a sheep model of smoke inhalation injury.
• Nebulized epinephrine shows promise as an immediate, on-site resuscitation tool for smoke inhalation victims.
• Further research is warranted to confirm the efficacy of nebulized epinephrine in human patients.